FindTrial
Sign In

Clinical research of CD45-TACs based method for the negative isolation of plasma cells

Clinical research of CD45-TACs based method for the negative isolation of plasma cells: a randomized controlled open study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009111
Enrollment
Unknown
Registered
2016-08-29
Start date
2016-08-05
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

Gold Standard:bone marrow puncture,Serum quantitative immunoglobulins,serum protein electrophoresis (SPEP),serum immunofixation electrophoresis(SIFE)
Index test:FISH&#32
IgH&#32
rearrangement,&#32
the&#32
expression&#32
of&#32
CD38,&#32
CD138&#32
by&#32
flow&#32
cytometry,FISH&#32
del&#32
(13q),&#32
FISH&#32
(17p),&#32
1q21&#32
gain&#32

Sponsors

Department of Hematology, Xinqiao Hospital,Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newly diagnosed multiple myeloma

Exclusion criteria

Exclusion criteria: 1. Multiple myeloma patients received treatment; 2. MGUS, Smoking multiple myeloma,Bone solitary/multiple plasmacytoma; 3. Secondary myelofibrosis and bone marrow failure.

Design outcomes

Primary

MeasureTime frame
FISH IgH rearrangement;—

Secondary

MeasureTime frame
the expression of CD38, CD138 by flow cytometry;FISH del (13q);FISH del (17p);FISH 1q21 gain;—

Countries

China

Contacts

Public ContactXi Zhang

Department of Hematology, Xinqiao Hospital, Chongqing

zhangxxi@sina.com+86 13808310064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026